b'<style type="text/css">\r\n\t\t\t.cs2E86D3A6{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt}\r\n\t\t\t.cs5925EB86{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:10pt;font-weight:bold;font-style:normal;}\r\n\t\t\t.cs95E872D0{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt}\r\n\t\t\t.csDD5E5F52{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:10pt;font-weight:normal;font-style:normal;}\r\n\t\t\t.csED7826F6{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:14pt;font-weight:bold;font-style:italic;}\r\n\t\t\t.csE0B838BE{text-align:justify;text-indent:-86pt;margin:0pt 0pt 0pt 86pt}\r\n\t\t\t.csA16174BA{color:#000000;background-color:transparent;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;}\r\n\t\t\t.cs9224F58F{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}\r\n\t\t\t.csC970676{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}\r\n\t\t\t.cs5ADD8C59{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:9pt;font-weight:normal;font-style:normal;}\r\n\t\t\t.csE2DB38B2{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:9pt;font-weight:bold;font-style:italic;}\r\n\t\t\t.cs5D3E032C{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:9pt;font-weight:normal;font-style:normal;text-decoration: line-through;}\r\n\t\t\t.cs41ED3027{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}\r\n\t\t\t.csE3E0FE0B{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:10pt;font-weight:normal;font-style:italic;}\r\n\t\t\t.cs5CA3ADAD{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 54pt;line-height:12pt;mso-line-height-rule:exactly}\r\n\t\t\t.csD15247B9{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}\r\n\t\t\t.csF0A1D375{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}\r\n\t\t\t.cs75F9B396{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}\r\n\t\t\t.cs2C11128C{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:12pt;font-weight:normal;font-style:normal;}\r\n\t\t\t.cs2222D344{text-align:center;text-indent:0pt;margin:3pt 0pt 3pt 0pt}\r\n\t\t\t.csE4480EBF{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:10pt;font-weight:bold;font-style:normal;text-transform:uppercase;}\r\n\t\t\t.cs2D2816FE{}\r\n\t\t\t.csD8C6AFB2{width:103.6pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:none;border-right:none;border-bottom:none;border-left:none}\r\n\t\t\t.cs2CD9A2D1{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:11pt;font-weight:bold;font-style:normal;}\r\n\t\t\t.cs22DBDE6C{width:193.5pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:none;border-right:none;border-bottom:none;border-left:none}\r\n\t\t\t.csEAEAF57{width:103.6pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:none;border-right:1pt #000000 solid;border-bottom:none;border-left:none}\r\n\t\t\t.csF27A2354{width:382.15pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}\r\n\t\t\t.cs5BCA4A20{width:103.6pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:none;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:none}\r\n\t\t\t.csA75787F1{width:94.5pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}\r\n\t\t\t.csF1FDEC69{width:99pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}\r\n\t\t\t.cs9FFB5A9D{width:89.65pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}\r\n\t\t\t.cs110AFF96{width:103.6pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}\r\n\t\t\t.cs1157FFE2{text-align:right;text-indent:0pt;margin:0pt 0pt 0pt 0pt}\r\n\t\t\t.cs425D253{width:103.6pt;padding:0pt 5.4pt 0pt 5.4pt;background-color:#D9D9D9;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}\r\n\t\t\t.cs22FF6315{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:10pt;font-weight:bold;font-style:italic;}\r\n\t\t\t.csF41A58B4{width:382.15pt;padding:0pt 5.4pt 0pt 5.4pt;background-color:#D9D9D9;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}\r\n\t\t\t.cs1B16EEB5{color:#000000;background-color:transparent;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;}\r\n\t\t\t.cs6A0709A4{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 24pt;line-height:1.5}\r\n\t\t\t.cs9E885863{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 18pt;line-height:1.5}\r\n\t\t\t.cs28DF8A12{text-align:left;margin:0pt 0pt 0pt 18pt;line-height:1.5;list-style-type:decimal;color:#000000;background-color:transparent;font-family:\'Times New Roman\';font-size:10pt;font-weight:normal;font-style:normal}\r\n\t\t\t.csF0A1C4DD{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:11pt;font-weight:normal;font-style:normal;}\r\n\t\t\t.csEC8EA14B{text-align:left;margin:0pt 0pt 0pt 0pt;line-height:1.5;list-style-type:disc;color:#000000;background-color:transparent;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal}\r\n\t\t</style>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\r\n\r\n\t\t<p class="cs2E86D3A6"><span class="cs5925EB86">HB 1634-FN-A - AS INTRODUCED</span></p><p class="cs2E86D3A6"><span class="cs5925EB86">&nbsp;</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">2022 SESSION</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">\t22-2090</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">\t05/10</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs95E872D0" style="tab-stops:left 108pt;"><span class="csDD5E5F52">HOUSE BILL\t</span><span class="csED7826F6">1634-FN-A</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT\t</span><a name="bkTitleDraft0"><span class="csDD5E5F52">relative to state grants for researching the effects on the human body of COVID-19 vaccines.</span></a></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="csE0B838BE" style="tab-stops:left 86.45pt;"><span class="csDD5E5F52">SPONSORS:\tRep. Greeson, Graf. 16</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="csE0B838BE" style="tab-stops:left 86.45pt;"><span class="csDD5E5F52">COMMITTEE:\tHealth, Human Services and Elderly Affairs</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csA16174BA">-----------------------------------------------------------------</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">ANALYSIS</span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs9224F58F" style="tab-stops:left 18pt left 86.45pt;"><span class="csDD5E5F52">\tThis bill establishes a COVID-19 research grant program in the department of health and human services and makes an appropriation for this purpose.</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs95E872D0"><span class="csDD5E5F52">- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - </span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">Explanation:\tMatter added to current law appears in </span><span class="csE2DB38B2">bold italics.</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">\t\tMatter removed from current law appears [</span><span class="cs5D3E032C">in brackets and struckthrough.</span><span class="cs5ADD8C59">]</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">\t\tMatter which is either (a) all new or (b) repealed and reenacted appears in regular type.</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">\t22-2090</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">\t05/10</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52">STATE OF NEW HAMPSHIRE</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">In the Year of Our Lord Two Thousand Twenty Two</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT\t</span><a name="bkTitleDraft1"><span class="csDD5E5F52">relative to state grants for researching the effects on the human body of COVID-19 vaccines.</span></a></p><p class="cs5CA3ADAD" style="tab-stops:left 396pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">Be it Enacted by the Senate and House of Representatives in General Court convened:</span></p><p class="csD15247B9"><span class="csDD5E5F52">&nbsp;</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt1"></a><span class="csDD5E5F52">1 &nbsp;Findings and Statement of Purpose. &nbsp;As much as is known about the virus commonly known as COVID-19, much more remains unknown. &nbsp;Further, advancements in technology that produced the new mRNA vaccine occurred so rapidly that full understanding of the effects of these vaccines on human bodies is not known and may not be fully known for many years to come.  Being such, knowledge comes from scientific study, and the earlier that study begins, the better everyone&rsquo;s understanding is. &nbsp;Therefore, the state shall establish a grant program for the purposes of researching the effects, if any, on the human body by vaccines administered to prevent the virus commonly known as COVID-19. &nbsp;</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt2"></a><span class="csDD5E5F52">2 &nbsp;New Subdivision; Communicable Disease; COVID-19 Research Grant Program. &nbsp;Amend RSA 141-C by inserting after section 28 the following new subdivision:</span></p><p class="cs75F9B396" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">COVID-19 Research Grant Program</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t141-C:29 &nbsp;COVID-19 Research Grant Program. &nbsp;The department of health and human services shall establish and administer a research grant program, the purpose of which shall be to research the effects on the human body of vaccines intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS&#8209;CoV&#8209;2), the virus that causes coronavirus disease 2019 (COVID&#8209;19). &nbsp;</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tI. &nbsp;In phase I of the program, grant recipients shall investigate the presence and severity of spike proteins in organs, including reproductive organs, and the locations of highest concentrations in human bodies at time of death. &nbsp;Comparisons shall be made to determine if there are any differences between those who were vaccinated against COVID-19 and those unvaccinated regarding the presence and severity of spike proteins and concentrations of spike proteins plus any other notable differences. &nbsp;</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(a) &nbsp;The maximum grant amount shall be $250,000 per applicant for direct costs with a cap on indirect costs set at 10 percent of direct costs. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(b) &nbsp;Phase I grant recipients shall complete their research within one year of receipt of grant funds and shall make their findings available to the public at no charge. &nbsp;Copies of findings shall be submitted to the governor&rsquo;s office and both houses of the legislature. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tII. &nbsp;In phase II of the program, grant recipients shall investigate whether those who had been vaccinated show any anomalies from what would otherwise be expected from the cause of death or whether vaccinated bodies demonstrate any deviations from those who died of the same cause prior to January 2020.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(a) &nbsp;The maximum grant amount shall be $250,000 per applicant for direct costs with a cap on indirect costs set at 10 percent of direct costs.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(b) &nbsp;Phase II grant recipients shall complete their research within one year of receipt of grant funds and shall make their findings public at no charge. &nbsp;Copies of findings shall be submitted to the governor&rsquo;s office and both houses of the legislature. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tIII. &nbsp;Based on an evaluation of the results from phase I, the department of health and human services shall recommend to the house committee on health, human services and elderly affairs and the senate committee on health and human services whether or not a phase II of the grant program is necessary. &nbsp;If phase II is recommended, upon concurrence of both committees, phase II shall be conducted. &nbsp;If phase II is not recommended, upon concurrence of both committees, phase II will not be conducted and any funds appropriated to the department for phase II of the program shall lapse to the general fund. &nbsp;If either committee disagrees with the recommendation, the recommendation shall be presented to both full chambers for vote and a majority of both chambers shall determine whether or not phase II is conducted. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tIV. &nbsp;The department shall adopt rules under RSA 541-A relative to administration of the research grant program, including the application procedure, eligibility criteria, grant disbursement, and reporting requirements.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt3"></a><span class="csDD5E5F52">3 &nbsp;Appropriation. &nbsp;The sum of $2,000,000 for the fiscal year ending June 30, 2022, is appropriated to the department of health and human services for the purpose of administering and funding phase I of the COVID-19 research grant program in RSA 141-C:29. &nbsp;The sum of $2,000,000 for the fiscal year ending June 30, 2023, is appropriated to the department of health and human services for the purpose of administering and funding phase II of the COVID-19 research grant program established in RSA 141-C:29. &nbsp;The source of funds for the appropriation shall be funds allocated to the state of New Hampshire pursuant to the American Rescue Plan Act of 2021, Public Law 117-2, and the appropriation shall be contingent upon determination that the research grant program is a federally permitted use of such funds. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt4"></a><span class="csDD5E5F52">4 &nbsp;Effective Date. &nbsp;This act shall take effect June 30, 2022.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="cs2C11128C">&nbsp;</span></p><p class="cs95E872D0" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt left 108pt left 244.8pt;"><a name="bkFiscalNote"><span class="csDD5E5F52">\t\t\t\t\t\t\t\t\t\t\tLBA</span></a></p><p class="cs95E872D0" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt left 108pt left 244.8pt;"><span class="csDD5E5F52">\t\t\t\t\t\t\t\t\t\t\t22-2090</span></p><p class="cs95E872D0" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt left 108pt left 244.8pt;"><span class="csDD5E5F52">\t\t\t\t\t\t\t\t\t\t\tRedraft 12/20/21</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs2222D344"><span class="csE4480EBF">HB 1634-FN-A- FISCAL NOTE</span></p><p class="cs2222D344"><span class="csE4480EBF">AS INTRODUCED</span></p><p class="csE0B838BE" style="tab-stops:left 85.5pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT\t</span><a name="bkTitleDraftFN0"><span class="csDD5E5F52">relative to state grants for researching the effects on the human body of COVID-19 vaccines.</span></a></p><p class="csD15247B9" style="tab-stops:left 85.5pt;"><span class="cs5925EB86">&nbsp;</span></p><p class="csD15247B9" style="tab-stops:left 85.5pt;"><span class="cs5925EB86">FISCAL IMPACT:</span><span class="csDD5E5F52"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="cs5925EB86">[ X ] State &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[ &nbsp;&nbsp;&nbsp;] County &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[ &nbsp;&nbsp;&nbsp;] Local &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[ &nbsp;&nbsp;&nbsp;] None</span></p><table class="cs2D2816FE" border="0" cellspacing="0" cellpadding="0" width="648" align="center" style="border-collapse:collapse;">\r\n\t\t\t<tr style="height:14.9pt;">\r\n\t\t\t\t<td class="csD8C6AFB2" width="139"><p class="cs95E872D0"><span class="cs2CD9A2D1">&nbsp;</span></p></td><td class="cs22DBDE6C" colspan="2" width="258"><p class="cs2E86D3A6"><span class="cs2CD9A2D1">&nbsp;</span></p></td></tr>\r\n\t\t\t<tr style="height:14.9pt;">\r\n\t\t\t\t<td class="csEAEAF57" valign="bottom" width="139"><p class="cs95E872D0"><span class="cs2CD9A2D1">&nbsp;</span></p></td><td class="csF27A2354" colspan="4" width="510"><p class="cs2E86D3A6"><span class="cs2CD9A2D1">Estimated Increase / (Decrease)</span></p></td></tr>\r\n\t\t\t<tr style="height:14.9pt;">\r\n\t\t\t\t<td class="cs5BCA4A20" width="139"><p class="cs95E872D0"><span class="cs5925EB86">STATE:</span></p></td><td class="csA75787F1" width="126"><p class="cs2E86D3A6"><span class="cs5925EB86">FY 2022</span></p></td><td class="csF1FDEC69" width="132"><p class="cs2E86D3A6"><span class="cs5925EB86">FY 2023</span></p></td><td class="csF1FDEC69" width="132"><p class="cs2E86D3A6"><span class="cs5925EB86">FY 2024</span></p></td><td class="cs9FFB5A9D" width="120"><p class="cs2E86D3A6"><span class="cs5925EB86">FY 2025</span></p></td></tr>\r\n\t\t\t<tr style="height:14.9pt;">\r\n\t\t\t\t<td class="cs110AFF96" width="139"><p class="cs95E872D0"><span class="cs5925EB86">&nbsp; &nbsp;Appropriation</span></p></td><td class="csA75787F1" width="126"><p class="cs1157FFE2"><span class="csDD5E5F52">$2,000,000</span></p></td><td class="csF1FDEC69" width="132"><p class="cs1157FFE2"><span class="csDD5E5F52">$2,000,000</span></p></td><td class="csF1FDEC69" width="132"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="cs9FFB5A9D" width="120"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td></tr>\r\n\t\t\t<tr style="height:14.9pt;">\r\n\t\t\t\t<td class="cs110AFF96" width="139"><p class="cs95E872D0"><span class="cs5925EB86">&nbsp; &nbsp;Revenue</span></p></td><td class="csA75787F1" width="126"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="csF1FDEC69" width="132"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="csF1FDEC69" width="132"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="cs9FFB5A9D" width="120"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td></tr>\r\n\t\t\t<tr style="height:14.9pt;">\r\n\t\t\t\t<td class="cs110AFF96" width="139"><p class="cs95E872D0"><span class="cs5925EB86">&nbsp; &nbsp;Expenditures</span></p></td><td class="csA75787F1" width="126"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="csF1FDEC69" width="132"><p class="cs1157FFE2"><span class="csDD5E5F52">$2,000,000</span></p></td><td class="csF1FDEC69" width="132"><p class="cs1157FFE2"><span class="csDD5E5F52">$2,000,000</span></p></td><td class="cs9FFB5A9D" width="120"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td></tr>\r\n\t\t\t<tr style="height:14.9pt;">\r\n\t\t\t\t<td class="cs425D253" width="139"><p class="cs95E872D0"><span class="cs22FF6315">Funding Source:</span></p></td><td class="csF41A58B4" colspan="4" width="510"><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp; </span><span class="cs1B16EEB5">[ &nbsp;&nbsp;&nbsp;] General &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[ &nbsp;&nbsp;&nbsp;] Education &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[ &nbsp;&nbsp;&nbsp;] Highway</span><span class="csDD5E5F52"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="cs1B16EEB5">[ X ] Other - Federal American Rescue Plan Act (ARPA) funds.</span><span class="cs5925EB86"> </span></p></td></tr>\r\n\t\t</table>\r\n\t\t<p class="cs6A0709A4"><span class="csDD5E5F52">&nbsp;</span></p><p class="csF0A1D375"><span class="cs5925EB86">METHODOLOGY:</span></p><p class="cs9E885863"><span class="csDD5E5F52">This bill establishes a COVID-19 vaccine research grant program within the Department of Health and Human Services. &nbsp;In each of the program&#39;s two phases, grant recipients would receive &nbsp;up to $250,000 apiece and be required to report on their findings within one year. &nbsp;The Department would administer the program, and is provided with rule making authority to establish procedures for applications, eligibility, grant disbursement, and reporting requirements. &nbsp;Following phase I of the program, the Department would be responsible for recommending to the House Committee on Health, Human Services, and Elderly Affairs whether the program should proceed with phase II. &nbsp;In the event phase II is not recommended, the bill states that the unspent phase II appropriation shall lapse to the general fund. &nbsp;As noted below, however, the source of the appropriation is federal American Rescue Plan Act (ARPA) funds, in which case unused money would not lapse to the general fund. &nbsp;The Department assumes its responsibilities for administering the program will include the following: &nbsp;</span></p><p class="cs9E885863"><span class="csDD5E5F52">&nbsp;</span></p><ol start="1" style="margin-top:0;margin-bottom:0;">\r\n\t\t\t<li class="cs28DF8A12"><span class="csDD5E5F52">Drafting administrative rules that outline procedures related to the program;</span></li><li class="cs28DF8A12"><span class="csDD5E5F52">Establishing an application process to award funding; </span></li><li class="cs28DF8A12"><span class="csDD5E5F52">Soliciting applications;</span></li><li class="cs28DF8A12"><span class="csDD5E5F52">Reviewing applications and awarding funding;</span></li><li class="cs28DF8A12"><span class="csDD5E5F52">Entering into contracts with recipients;</span></li><li class="cs28DF8A12"><span class="csDD5E5F52">Monitoring contract performance measures and vendor activities; and</span></li><li class="cs28DF8A12"><span class="csDD5E5F52">Paying invoices. </span></li></ol>\r\n\t\t<p class="csF0A1D375"><span class="csDD5E5F52">&nbsp;</span></p><p class="csF0A1D375"><span class="csDD5E5F52">The bill contains ARPA appropriations of $2 million in each of FY22 and FY23 for the purpose of funding operations and awarding grants. &nbsp;The Department anticipates utilizing the entire appropriation. &nbsp;The Department estimates administrative costs at approximately $269,000 per year, broken out as follows:</span></p><p class="csD15247B9"><span class="csF0A1C4DD">&nbsp;</span></p><ul style="margin-top:0;margin-bottom:0;">\r\n\t\t\t<li class="csEC8EA14B"><span class="csDD5E5F52">Personnel &ndash; Program Specialist IV &ndash; Salary: $52,156</span></li><li class="csEC8EA14B"><span class="csDD5E5F52">Personnel &ndash; Program Specialist IV &ndash; Benefits: $31,097</span></li><li class="csEC8EA14B"><span class="csDD5E5F52">Current Expenses: $1,200</span></li><li class="csEC8EA14B"><span class="csDD5E5F52">Computer Equipment and Software: $2,000</span></li><li class="csEC8EA14B"><span class="csDD5E5F52">Allocated costs (rent, telecommunications, IT support, etc): $182,000</span></li></ul>\r\n\t\t<p class="csF0A1D375"><span class="csDD5E5F52">&nbsp;</span></p><p class="csF0A1D375"><span class="csDD5E5F52">The Department anticipates spending the remaining $1,731,000 per year on grant awards. It should be noted that the bill&#39;s effective date is June 30, 2022, allowing the FY22 appropriation to take effect. Since the funding source is federal ARPA money rather than state general funds, this fiscal note assumes that the funds will not lapse but will be available for expenditure in FY23 and FY24. </span></p><p class="csF0A1D375"><span class="csDD5E5F52">&nbsp;</span></p><p class="csF0A1D375"><span class="cs5925EB86">AGENCIES CONTACTED:</span></p><p class="cs9E885863"><span class="csDD5E5F52">Department of Health and Human Services</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="cs2C11128C">&nbsp;</span></p>'